Designing and evaluation of rapid molecular assays for first and second-line anti-tuberculosis drugs

Designing and evaluation of rapid molecular assays for first and second-line anti-tuberculosis drugs

Introduction: The four basic or “first-line” TB drugs are Isoniazid, Rifampicin, Pyrazinamide and Ethambutol. For the treatment of drug-resistant TB, the current TB drugs are grouped according to their effectiveness and experience of use, such as Streptomycin, pyrazinamide, rifabutin, kanamycin, ami...

Full description

Bibliographic Details
Main Authors: M Arjomandzadegan, A Ahmadi, F Salehi, V Vahidi, T Poolad, M Sadrnia, M Kahbazi, M Abkar, M Taherahmady, S Geravand, S Moazami, S Falahat, M Tayeboon, H Bornasi, S Mosabebi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:International Journal of Mycobacteriology
Subjects:
Mycobacterium tuberculosis
Drug resistance
Rapid detection
PCR-RFLP
MAS-PCR
Sequencing
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=109;epage=109;aulast=Arjomandzadegan;type=0

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=109;epage=109;aulast=Arjomandzadegan;type=0

Similar Items